Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Thompson

Showing results (231-240 of 358) with videos related to

Pageof 36
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1992
Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteersJ A Smithers, H K Kulmala, G A Thompson, et al.
Journal of Clinical Pharmacology|March 10, 2000
Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteersD Y Mitchell, R A Eusebio, N A Sacco-Gibson, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Effect of renal function on risedronate pharmacokinetics after a single oral doseD Y Mitchell, J V St Peter, R A Eusebio, et al.
PLOS Mental Health|February 9, 2026
Depression and its associated factors among people living with HIV in the Volta region of GhanaJerry John Nutor, Robert Kaba Alhassan, Rachel G A Thompson, et al.
AIDS Research and Therapy|June 29, 2023
Influence of depression and interpersonal support on adherence to antiretroviral therapy among people living with HIVJerry John Nutor, Akua O Gyamerah, Robert Kaba Alhassan, et al.
Journal of Pharmaceutical Sciences|November 1, 1996
Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteersG A Thompson, J V St Peter, M A Heise, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2016
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosisS A Harrison, S R Marri, N Chalasani, et al.
Physical Review Letters|September 26, 2012
Evidence for the charmless annihilation decay mode B(s)(0)→π(+)π(-)T Aaltonen, B Alvarez González, S Amerio, et al.
Physical Review Letters|June 15, 2011
Search for production of heavy particles decaying to top quarks and invisible particles in pp collisions at √s = 1.96  TeVT Aaltonen, B Álvarez González, S Amerio, et al.
Pageof 36

Showing results (231-240 of 358) with videos related to

Sort By:
Pageof 36
Antimicrobial Agents and Chemotherapy|January 1, 1992
Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteersJ A Smithers, H K Kulmala, G A Thompson, et al.
Journal of Clinical Pharmacology|March 10, 2000
Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteersD Y Mitchell, R A Eusebio, N A Sacco-Gibson, et al.
British Journal of Clinical Pharmacology|March 16, 2000
Effect of renal function on risedronate pharmacokinetics after a single oral doseD Y Mitchell, J V St Peter, R A Eusebio, et al.
PLOS Mental Health|February 9, 2026
Depression and its associated factors among people living with HIV in the Volta region of GhanaJerry John Nutor, Robert Kaba Alhassan, Rachel G A Thompson, et al.
AIDS Research and Therapy|June 29, 2023
Influence of depression and interpersonal support on adherence to antiretroviral therapy among people living with HIVJerry John Nutor, Akua O Gyamerah, Robert Kaba Alhassan, et al.
Journal of Pharmaceutical Sciences|November 1, 1996
Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteersG A Thompson, J V St Peter, M A Heise, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2016
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosisS A Harrison, S R Marri, N Chalasani, et al.
Physical Review Letters|September 26, 2012
Evidence for the charmless annihilation decay mode B(s)(0)→π(+)π(-)T Aaltonen, B Alvarez González, S Amerio, et al.
Physical Review Letters|June 15, 2011
Search for production of heavy particles decaying to top quarks and invisible particles in pp collisions at √s = 1.96  TeVT Aaltonen, B Álvarez González, S Amerio, et al.
Pageof 36